glp-1 receptor agonists list America's Poison Centers glp-1 receptor agonist drug names

Currently, the FDA is advising against the use of GLP1 agonists in people at risk for MTC or MEN2 syndrome ( N Engl J Med

Recent studies have indicated that the protective properties against endothelial dysfunction, anti-inflammatory effects on macrophages and the anti-proliferative action on smooth muscle cells may contribute to atheroprotection through GLP-1R signaling

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

These medications are not insulin, and you dont have to monitor your blood sugars unless directed by your health care team

GLP-1 also slows down how fast our stomach empties, which helps control how quickly food gets into our bloodstream

According to reported trial data, adults taking the 12 mg dose lost an average of 70.3 pounds, equal to about 28.3% of body weight, over 80 weeks